GEN Exclusives

More »

GEN News Highlights

More »
Nov 7, 2012

A Universal Flu Vaccine Without Needles

  • MonoSol Rx and BiondVax are working together to develop an oral film formulation of the universal flu vaccine, M-001. MonoSol Rx is the developer of PharmFilm® drug delivery technology, and BiondVax is an Israeli-based pharmaceutical company that has developed the universal flu vaccine M-001. According to MonoSol Rx, there are significant advantages for this needle-free delivery in vaccines, including ease of use, increased compliance, and simplified distribution.

    The collaboration will include the conduction of studies using MonoSol Rx' PharmFilm technology to investigate the activity and formulation of BiondVax influenza vaccine when delivered in an oral film.

    A. Mark Schobel, co-president and chief executive officer of MonoSol Rx, stated, "We have believed for some time in the significant advantages PharmFilm can offer in the delivery of a broad range of vaccines. . . . We believe that the targeted oral, needle-free influenza vaccine enabled by the PharmFilm platform will see increased patient acceptance, leading to a better-protected population. Storage and distribution will also be enhanced by the film formulation, which is stable at room temperature, making vaccination easier for large numbers of patients across the country."

    PharmFilm is a quick-dissolving, taste-masked dissolvable film that, according to MonoSol Rx, has the potential for faster onset and more precise dosing for patients whose medical conditions or profile make compliance with traditional drug delivery forms challenging. BiondVax’ universal flu vaccine, the M-001, is based on a combination of conserved nonchanging epitopes, or peptides, common to existing and future flu virus strains including both seasonal and pandemic flu strains, such as the avian and swine flu, regardless of their antigenic drift and shifts.


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?